Titre : Chimérisme

Chimérisme : Questions médicales fréquentes

Termes MeSH sélectionnés :

Cluster Analysis
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Chimérisme : Questions médicales les plus fréquentes", "headline": "Chimérisme : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Chimérisme : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-04-28", "dateModified": "2025-04-23", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Chimérisme" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Aberrations des chromosomes", "url": "https://questionsmedicales.fr/mesh/D002869", "about": { "@type": "MedicalCondition", "name": "Aberrations des chromosomes", "code": { "@type": "MedicalCode", "code": "D002869", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "G05.365.590.175" } } }, "about": { "@type": "MedicalCondition", "name": "Chimérisme", "alternateName": "Chimerism", "code": { "@type": "MedicalCode", "code": "D046528", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "Hui Li", "url": "https://questionsmedicales.fr/author/Hui%20Li", "affiliation": { "@type": "Organization", "name": "Department of Biochemistry and Molecular Genetics, School of Medicine, University of Virginia, Charlottesville, VA, United States; Department of Pathology, School of Medicine, University of Virginia, Charlottesville, VA, United States. Electronic address: hl9r@virginia.edu." } }, { "@type": "Person", "name": "Sandeep Singh", "url": "https://questionsmedicales.fr/author/Sandeep%20Singh", "affiliation": { "@type": "Organization", "name": "Department of Pathology, School of Medicine, University of Virginia, Charlottesville, VA, United States." } }, { "@type": "Person", "name": "Hao Zhang", "url": "https://questionsmedicales.fr/author/Hao%20Zhang", "affiliation": { "@type": "Organization", "name": "Institute of Precision Cancer Medicine and Pathology, Jinan University Medical College, Guangzhou, Guangdong, China. haozhang@jnu.edu.cn." } }, { "@type": "Person", "name": "Xinrui Shi", "url": "https://questionsmedicales.fr/author/Xinrui%20Shi", "affiliation": { "@type": "Organization", "name": "Department of Biochemistry and Molecular Genetics, School of Medicine, University of Virginia, Charlottesville, VA, United States." } }, { "@type": "Person", "name": "Yusheng Lin", "url": "https://questionsmedicales.fr/author/Yusheng%20Lin", "affiliation": { "@type": "Organization", "name": "Institute of Precision Cancer Medicine and Pathology, Jinan University Medical College, Guangzhou, Guangdong, China." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "Repurposing the Ordering of Routine Laboratory Tests in Hospitalised Medical Patients (RePORT): results of a cluster randomised stepped-wedge quality improvement study.", "datePublished": "2023-05-10", "url": "https://questionsmedicales.fr/article/37164639", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1136/bmjqs-2022-015611" } }, { "@type": "ScholarlyArticle", "name": "Enhancing the Cardiovascular Safety of Hemodialysis Care Using Multimodal Provider Education and Patient Activation Interventions: Protocol for a Cluster Randomized Controlled Trial.", "datePublished": "2023-04-20", "url": "https://questionsmedicales.fr/article/37079365", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.2196/46187" } }, { "@type": "ScholarlyArticle", "name": "Hydrogen-Rich Pyrolysis from Ni-Fe Heterometallic Schiff Base Centrosymmetric Cluster Facilitates NiFe Alloy for Efficient OER Electrocatalysts.", "datePublished": "2023-03-15", "url": "https://questionsmedicales.fr/article/36922744", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1002/smll.202208276" } }, { "@type": "ScholarlyArticle", "name": "High-Density NiCu Bimetallic Phosphide Nanosheet Clusters Constructed by Cu-Induced Effect Boost Total Urea Hydrolysis for Hydrogen Production.", "datePublished": "2023-03-09", "url": "https://questionsmedicales.fr/article/36893334", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1021/acs.inorgchem.3c00082" } }, { "@type": "ScholarlyArticle", "name": "Enhancer Clusters Drive Type I Interferon-Induced TRAIL Overexpression in Cancer, and Its Intracellular Protein Accumulation Fails to Induce Apoptosis.", "datePublished": "2023-02-03", "url": "https://questionsmedicales.fr/article/36765925", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.3390/cancers15030967" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Phénomènes génétiques", "item": "https://questionsmedicales.fr/mesh/D055614" }, { "@type": "ListItem", "position": 3, "name": "Variation génétique", "item": "https://questionsmedicales.fr/mesh/D014644" }, { "@type": "ListItem", "position": 4, "name": "Mutation", "item": "https://questionsmedicales.fr/mesh/D009154" }, { "@type": "ListItem", "position": 5, "name": "Aberrations des chromosomes", "item": "https://questionsmedicales.fr/mesh/D002869" }, { "@type": "ListItem", "position": 6, "name": "Chimérisme", "item": "https://questionsmedicales.fr/mesh/D046528" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Chimérisme - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Chimérisme", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-02", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Chimérisme", "description": "Comment diagnostiquer le chimérisme ?\nQuels tests sont utilisés pour le chimérisme ?\nLe chimérisme peut-il être détecté par échographie ?\nQuels signes cliniques peuvent indiquer un chimérisme ?\nLe chimérisme est-il héréditaire ?", "url": "https://questionsmedicales.fr/mesh/D046528?mesh_terms=Cluster+Analysis&page=1000#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Chimérisme", "description": "Quels sont les symptômes du chimérisme ?\nLe chimérisme cause-t-il des douleurs ?\nPeut-on avoir des symptômes sans chimérisme ?\nLe chimérisme affecte-t-il la croissance ?\nY a-t-il des symptômes spécifiques au chimérisme ?", "url": "https://questionsmedicales.fr/mesh/D046528?mesh_terms=Cluster+Analysis&page=1000#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Chimérisme", "description": "Peut-on prévenir le chimérisme ?\nY a-t-il des facteurs de risque pour le chimérisme ?\nLes tests prénataux peuvent-ils détecter le chimérisme ?\nLe chimérisme est-il lié à des pratiques médicales ?\nLes femmes enceintes doivent-elles se méfier du chimérisme ?", "url": "https://questionsmedicales.fr/mesh/D046528?mesh_terms=Cluster+Analysis&page=1000#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Chimérisme", "description": "Comment traiter le chimérisme ?\nLe chimérisme nécessite-t-il une intervention chirurgicale ?\nLes médicaments peuvent-ils aider au chimérisme ?\nY a-t-il des traitements naturels pour le chimérisme ?\nLe suivi médical est-il nécessaire pour le chimérisme ?", "url": "https://questionsmedicales.fr/mesh/D046528?mesh_terms=Cluster+Analysis&page=1000#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Chimérisme", "description": "Quelles complications peuvent survenir avec le chimérisme ?\nLe chimérisme peut-il causer des cancers ?\nComment gérer les complications du chimérisme ?\nLe chimérisme affecte-t-il le système immunitaire ?\nY a-t-il des risques de rejet avec le chimérisme ?", "url": "https://questionsmedicales.fr/mesh/D046528?mesh_terms=Cluster+Analysis&page=1000#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Chimérisme", "description": "Quels sont les facteurs de risque du chimérisme ?\nLe chimérisme est-il plus fréquent chez certaines populations ?\nLes greffes augmentent-elles le risque de chimérisme ?\nLes antécédents médicaux influencent-ils le chimérisme ?\nLe chimérisme est-il lié à des facteurs environnementaux ?", "url": "https://questionsmedicales.fr/mesh/D046528?mesh_terms=Cluster+Analysis&page=1000#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment diagnostiquer le chimérisme ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "Le diagnostic se fait par analyse génétique, notamment par PCR ou séquençage." } }, { "@type": "Question", "name": "Quels tests sont utilisés pour le chimérisme ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Les tests incluent l'analyse de l'ADN, les tests de compatibilité tissulaire et les marqueurs génétiques." } }, { "@type": "Question", "name": "Le chimérisme peut-il être détecté par échographie ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Non, l'échographie ne peut pas détecter le chimérisme, seul un test génétique est fiable." } }, { "@type": "Question", "name": "Quels signes cliniques peuvent indiquer un chimérisme ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "Des signes cliniques peuvent inclure des anomalies immunitaires ou des différences phénotypiques." } }, { "@type": "Question", "name": "Le chimérisme est-il héréditaire ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "Non, le chimérisme n'est généralement pas héréditaire, il résulte d'événements embryonnaires." } }, { "@type": "Question", "name": "Quels sont les symptômes du chimérisme ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Les symptômes varient, mais peuvent inclure des anomalies cutanées ou des troubles immunitaires." } }, { "@type": "Question", "name": "Le chimérisme cause-t-il des douleurs ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Le chimérisme en soi ne cause pas de douleurs, mais des complications peuvent en entraîner." } }, { "@type": "Question", "name": "Peut-on avoir des symptômes sans chimérisme ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Oui, de nombreux symptômes peuvent être causés par d'autres conditions médicales." } }, { "@type": "Question", "name": "Le chimérisme affecte-t-il la croissance ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Il peut affecter la croissance si des anomalies génétiques ou hormonales sont présentes." } }, { "@type": "Question", "name": "Y a-t-il des symptômes spécifiques au chimérisme ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Des différences de pigmentation ou des anomalies immunitaires peuvent être spécifiques." } }, { "@type": "Question", "name": "Peut-on prévenir le chimérisme ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "Le chimérisme ne peut pas être prévenu car il résulte d'événements embryonnaires." } }, { "@type": "Question", "name": "Y a-t-il des facteurs de risque pour le chimérisme ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Les facteurs de risque incluent des grossesses multiples ou des transfusions sanguines." } }, { "@type": "Question", "name": "Les tests prénataux peuvent-ils détecter le chimérisme ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "Les tests prénataux standard ne détectent pas le chimérisme, des tests génétiques spécifiques sont nécessaires." } }, { "@type": "Question", "name": "Le chimérisme est-il lié à des pratiques médicales ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "Oui, certaines pratiques comme les greffes peuvent augmenter le risque de chimérisme." } }, { "@type": "Question", "name": "Les femmes enceintes doivent-elles se méfier du chimérisme ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "Il n'y a pas de mesures préventives spécifiques pour les femmes enceintes concernant le chimérisme." } }, { "@type": "Question", "name": "Comment traiter le chimérisme ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "Le traitement dépend des symptômes et peut inclure des thérapies immunosuppressives." } }, { "@type": "Question", "name": "Le chimérisme nécessite-t-il une intervention chirurgicale ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "Rarement, sauf si des complications graves nécessitent une intervention spécifique." } }, { "@type": "Question", "name": "Les médicaments peuvent-ils aider au chimérisme ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des médicaments immunosuppresseurs peuvent être prescrits pour gérer les symptômes." } }, { "@type": "Question", "name": "Y a-t-il des traitements naturels pour le chimérisme ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "Il n'existe pas de traitements naturels prouvés pour le chimérisme, consultez un médecin." } }, { "@type": "Question", "name": "Le suivi médical est-il nécessaire pour le chimérisme ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "Oui, un suivi régulier est essentiel pour surveiller les complications potentielles." } }, { "@type": "Question", "name": "Quelles complications peuvent survenir avec le chimérisme ?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "Les complications incluent des troubles immunitaires, des rejets de greffe ou des cancers." } }, { "@type": "Question", "name": "Le chimérisme peut-il causer des cancers ?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "Oui, certaines formes de chimérisme peuvent augmenter le risque de cancers spécifiques." } }, { "@type": "Question", "name": "Comment gérer les complications du chimérisme ?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "La gestion implique un suivi médical régulier et des traitements adaptés aux symptômes." } }, { "@type": "Question", "name": "Le chimérisme affecte-t-il le système immunitaire ?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le chimérisme peut entraîner des dysfonctionnements du système immunitaire." } }, { "@type": "Question", "name": "Y a-t-il des risques de rejet avec le chimérisme ?", "position": 25, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le rejet peut survenir si des cellules étrangères sont reconnues par le système immunitaire." } }, { "@type": "Question", "name": "Quels sont les facteurs de risque du chimérisme ?", "position": 26, "acceptedAnswer": { "@type": "Answer", "text": "Les grossesses multiples et les transfusions sanguines sont des facteurs de risque connus." } }, { "@type": "Question", "name": "Le chimérisme est-il plus fréquent chez certaines populations ?", "position": 27, "acceptedAnswer": { "@type": "Answer", "text": "Il n'y a pas de données précises, mais les grossesses multiples peuvent augmenter le risque." } }, { "@type": "Question", "name": "Les greffes augmentent-elles le risque de chimérisme ?", "position": 28, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les greffes d'organes peuvent introduire des cellules étrangères, entraînant un chimérisme." } }, { "@type": "Question", "name": "Les antécédents médicaux influencent-ils le chimérisme ?", "position": 29, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des antécédents de transfusions ou de greffes peuvent augmenter le risque de chimérisme." } }, { "@type": "Question", "name": "Le chimérisme est-il lié à des facteurs environnementaux ?", "position": 30, "acceptedAnswer": { "@type": "Answer", "text": "Actuellement, il n'existe pas de preuves solides liant le chimérisme à des facteurs environnementaux." } } ] } ] }

Sources (10000 au total)

Repurposing the Ordering of Routine Laboratory Tests in Hospitalised Medical Patients (RePORT): results of a cluster randomised stepped-wedge quality improvement study.

Low-value use of laboratory tests is a global challenge. Our objective was to evaluate an intervention bundle to reduce repetitive use of routine laboratory testing in hospitalised patients.... We used a stepped-wedge design to implement an intervention bundle across eight medical units. Our intervention included educational tools and social comparison reports followed by peer-facilitated re... We included a total of 125 854 patient-days. Patient groups were similar in age, sex, Charlson Comorbidity Index and length of stay during the control, intervention and follow-up periods. From the con... A multifaceted intervention bundle using education and facilitated multilevel social comparison was associated with a safe and effective reduction in use of routine daily laboratory testing in hospita...

Enhancing the Cardiovascular Safety of Hemodialysis Care Using Multimodal Provider Education and Patient Activation Interventions: Protocol for a Cluster Randomized Controlled Trial.

End-stage kidney disease (ESKD) is treated with dialysis or kidney transplantation, with most patients with ESKD receiving in-center hemodialysis treatment. This life-saving treatment can result in ca... This study aims to evaluate the independent and comparative effectiveness of 2 interventions-one directed at hemodialysis providers and another for patients-in reducing the rate of IDH at hemodialysis... This study is a pragmatic, cluster randomized trial to be conducted in 20 hemodialysis facilities in the United States. Hemodialysis facilities will be randomized using a 2 × 2 factorial design, such ... This study is funded by the Patient-Centered Outcomes Research Institute and approved by the University of Michigan Medical School's institutional review board. The study began enrolling patients in J... The effects of provider and patient education on reducing the proportion of sessions with IDH and improving other patient-centered clinical outcomes will be evaluated, and the findings will be used to... ClinicalTrials.gov NCT03171545; https://clinicaltrials.gov/ct2/show/NCT03171545.... PRR1-10.2196/46187....

Evaluation of a cluster-randomized controlled trial: Communities for Healthy Living, family-centered obesity prevention program for Head Start parents and children.

This study reports the outcomes of Communities for Healthy Living (CHL), a cluster randomized obesity prevention trial implemented in partnership with Head Start, a federally-funded preschool program ... Using a stepped wedge design, Head Start programs (n = 16; Boston, MA, USA) were randomly assigned to one of three intervention start times. CHL involved a media campaign and enhanced nutrition suppor... During intervention periods (vs. control), children experienced greater increases in BMIz and modified BMIz (b = 0.06, 95% CI = 0.02,0.10; b = 0.07, 95% CI = 0.03, 0.12), yet were more likely to meet ... Interventions that emphasize parent engagement may increase parental empowerment. Intervention exposure was associated with statistically, but not clinically, significant increases in BMIz and increas... ClinicalTrials.gov, NCT03334669 , Registered October 2017....

Improving knowledge, attitudes, and practices on dengue and diarrhea in rural primary school students, their parents, and teachers in Colombia: A cluster-randomized controlled trial.

Improved education on water-related diseases in schools could help to reduce disease burden. This paper presents specific results on knowledge, attitudes and practices (KAP) of a cluster-randomized co... A factorial cluster-randomized controlled trial was carried out in 35 rural primary schools in two municipalities in Cundinamarca, central Colombia. Schools were randomized into four arms: interventio... There were increases in knowledge scores among students, their teachers and their parents for both diseases. However, the attitudes and practices components were not affected to the same extent. The h... ISRCTN40195031 The trial is registered in the Current Controlled Trials under Infections and Infestations category....

A peer-facilitated psychological group intervention for perinatal women living with HIV and depression in Tanzania-Healthy Options: A cluster-randomized controlled trial.

Perinatal women living with HIV (PWLH) have a greater risk of depression compared to other women; however, there are limited specialized mental health services available to them. We aimed to determine... Healthy Options is a cluster-randomized controlled study conducted in 16 government-managed antenatal care clinics that provided HIV care for pregnant women in urban Tanzania. Recruitment occurred fro... The Healthy Options intervention did not demonstrate reduction in depressive symptoms at 9 months postpartum, the primary outcome. Significant reductions were seen in depression symptoms at 6 weeks po... Clinical Trial registration number (closed to new participants) NCT02039973....